Profile
Susan B. Stewart currently works at Regulatory Affairs Professionals Society, as Director, Candel Therapeutics, Inc., as Chief Regulatory Officer from 2020, and Rezolute, Inc., as Chief Regulatory Officer from 2022.
Ms. Stewart also formerly worked at MG Biotherapeutics LLC, as Director, VP-Quality & Regulatory Affairs in 2005, Abbott Laboratories, as Vice President-Regulatory Affairs, Diacrin, Inc. (Delaware), as Principal, Genzyme Corp., as Vice President-Regulatory Affairs from 2001 to 2005, Tokai Pharmaceuticals, Inc., as SVP-Regulatory Affairs, Quality & Compliance from 2009 to 2015, Kaleido Biosciences, Inc., as Chief Regulatory Officer from 2020 to 2022, Frequency Therapeutics, Inc., as Chief Regulatory Officer, resTORbio, Inc., as Head-Regulatory Affairs, and TransMolecular, Inc., as Vice President-Regulatory Affairs from 2005 to 2010.
Ms. Stewart received her undergraduate degree from the University of Massachusetts, graduate degree from Concord Law School, and graduate degree from Maurice A. Deane School of Law at Hofstra University.
Susan Stewart active positions
| Companies | Position | Start |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | General Counsel | 30/09/2020 |
| REZOLUTE, INC. | General Counsel | 31/12/2021 |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Director/Board Member | - |
Former positions of Susan Stewart
| Companies | Position | End |
|---|---|---|
| KORRO BIO, INC. | General Counsel | 29/04/2023 |
| KALEIDO BIOSCIENCES, INC. | General Counsel | 31/03/2022 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Compliance Officer | 31/12/2014 |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | General Counsel | 31/12/2009 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 31/12/2004 |
Training of Susan Stewart
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Health Technology |
MG Biotherapeutics LLC | |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Concord Law School
Concord Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Rezolute, Inc.
Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Maurice A. Deane School of Law at Hofstra University
Maurice A. Deane School of Law at Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Susan Stewart
















